246 related articles for article (PubMed ID: 35741027)
21. Omeprazole Administration in Preterm Preeclampsia: a Randomized Controlled Trial to Study Its Effect on sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1), PlGF (Placental Growth Factor), and ET-1 (Endothelin-1).
Neuman RI; Baars MD; Saleh L; Broekhuizen M; Nieboer D; Cornette J; Schoenmakers S; Verhoeven M; Koch BCP; Russcher H; van den Berg SAA; van den Meiracker AH; Visser W; Danser AHJ
Hypertension; 2022 Jun; 79(6):1297-1307. PubMed ID: 35341328
[TBL] [Abstract][Full Text] [Related]
22. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
[TBL] [Abstract][Full Text] [Related]
23. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
24. NFAT5 Is Up-Regulated by Hypoxia: Possible Implications in Preeclampsia and Intrauterine Growth Restriction.
Dobierzewska A; Palominos M; Irarrazabal CE; Sanchez M; Lozano M; Perez-Sepulveda A; Monteiro LJ; Burmeister Y; Figueroa-Diesel H; Rice GE; Illanes SE
Biol Reprod; 2015 Jul; 93(1):14. PubMed ID: 25995271
[TBL] [Abstract][Full Text] [Related]
25. Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers?
Zhang K; Zen M; Popovic NL; Lee VW; Alahakoon TI
J Obstet Gynaecol Res; 2019 Sep; 45(9):1828-1836. PubMed ID: 31257726
[TBL] [Abstract][Full Text] [Related]
26. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.
Brownfoot FC; Hannan NJ; Cannon P; Nguyen V; Hastie R; Parry LJ; Senadheera S; Tuohey L; Tong S; Kaitu'u-Lino TJ
EBioMedicine; 2019 Mar; 41():636-648. PubMed ID: 30824385
[TBL] [Abstract][Full Text] [Related]
27. Comparison of circulating total sFLT-1 to placental-specific sFLT-1 e15a in women with suspected preeclampsia.
Rowson S; Reddy M; De Guingand DL; Langston-Cox A; Marshall SA; da Silva Costa F; Palmer KR
Placenta; 2022 Mar; 120():73-78. PubMed ID: 35227983
[TBL] [Abstract][Full Text] [Related]
28. LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast.
de Alwis N; Beard S; Binder NK; Pritchard N; Kaitu'u-Lino TJ; Walker SP; Stock O; Groom KM; Petersen S; Henry A; Said JM; Seeho S; Kane SC; Tong S; Hannan NJ
Pregnancy Hypertens; 2021 Aug; 25():255-261. PubMed ID: 34325289
[TBL] [Abstract][Full Text] [Related]
29. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1α mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells.
Maebayashi Asanuma A; Yamamoto T; Azuma H; Kato E; Yamamoto N; Murase T; Chishima F; Suzuki M
J Obstet Gynaecol Res; 2014 Oct; 40(10):2095-103. PubMed ID: 25132343
[TBL] [Abstract][Full Text] [Related]
30. Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.
Tan L; Chen Z; Sun F; Zhou Z; Zhang B; Wang B; Chen J; Li M; Xiao T; Neuman RI; Niu J; Verdonk K; Lu X; Zhang JV; Danser AHJ; Yang Q; Fan X
Clin Sci (Lond); 2022 Feb; 136(4):257-272. PubMed ID: 35103285
[TBL] [Abstract][Full Text] [Related]
31. Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK/AP-1 pathway in human trophoblast and endothelial cells.
Lin L; Li G; Zhang W; Wang YL; Yang H
J Cell Physiol; 2019 Aug; 234(10):18928-18941. PubMed ID: 31004367
[TBL] [Abstract][Full Text] [Related]
32. HIF-2α, but not HIF-1α, mediates hypoxia-induced up-regulation of Flt-1 gene expression in placental trophoblasts.
Sasagawa T; Nagamatsu T; Morita K; Mimura N; Iriyama T; Fujii T; Shibuya M
Sci Rep; 2018 Nov; 8(1):17375. PubMed ID: 30478339
[TBL] [Abstract][Full Text] [Related]
33. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta.
Nevo O; Lee DK; Caniggia I
PLoS One; 2013; 8(11):e81176. PubMed ID: 24260556
[TBL] [Abstract][Full Text] [Related]
35. Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia.
Tang P; Xu J; Xie BJ; Wang QM
Hypertens Pregnancy; 2017 Feb; 36(1):48-52. PubMed ID: 27834501
[TBL] [Abstract][Full Text] [Related]
36. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
[TBL] [Abstract][Full Text] [Related]
37. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
[TBL] [Abstract][Full Text] [Related]
38. Altered release of thrombomodulin and HMGB1 in the placenta complicated with preeclampsia.
Oda H; Nagamatsu T; Iriyama T; Osuga Y
Placenta; 2024 Mar; 148():12-19. PubMed ID: 38330539
[TBL] [Abstract][Full Text] [Related]
39. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
[TBL] [Abstract][Full Text] [Related]
40. Comparison of ophthalmic artery Doppler with PlGF and sFlt-1/PlGF ratio at 35-37 weeks' gestation in prediction of imminent pre-eclampsia.
Lau K; Wright A; Sarno M; Kametas NA; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 May; 59(5):606-612. PubMed ID: 35132725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
